Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeuticsDaisuke Ogiya(Tokai University), Sophia Adamia(Harvard University)Blood Cancer JournalFebruary 3, 202310.1038/s41408-023-00791-0Cited by 3SaveCiteExport RISWatch citationsRelated PapersThe JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implications|Blood|2020|87Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma|Leukemia|2022|29